Prevalence and Pattern of Lymph Node Metastasis in Malignant Pleural Mesothelioma

Annals of Thoracic Surgery

Volumn 86, Issue 2, 2008, Pages 391-395

  Abdel Rahman, Abdel Rahman M ^a   Gaafar, Rabab M ^a   Baki, Hoda A ^a   El Hosieny, Hesham M ^a   Aboulkasem, Fatma ^a   Farahat, Eman G ^a   Nouh, Akram M ^a   Mansour, Kamal A ^b  

^a NATIONAL CANCER INSTITUTE   (Egypt)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER THERAPY; DISSECTION; FEMALE; HUMAN; HUMAN TISSUE; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; MALIGNANT PLEURAL MESOTHELIOMA; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; OBSERVATIONAL STUDY; PATHOLOGY; PLEURA; PLEURA MESOTHELIOMA; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL;

DISEASE PROGRESSION; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEDIASTINOSCOPY; MESOTHELIOMA; NEOPLASM INVASIVENESS; PLEURAL NEOPLASMS; PNEUMONECTOMY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 47149086440     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.04.012     Document Type: Article

References (20)

1. Antman K.H. Clinical presentation and natural history of benign and malignant mesothelioma. Semin Oncol 8 (1981) 313-320
2. Baldini E.H., Recht A., Strauss G.M., et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 63 (1997) 334-338
3. Sugarbaker D.J., Strauss G.M., Lynch T.J., et al. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol 11 (1993) 1172-1178
4. Rusch V.W. A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 108 (1995) 1122-1128
5. Steele J.P., Klabatsa A., Fennell D.A., Pallaska A., Sheaff M.T., Evans M.T., et al. Prognostic factors in mesothelioma. Lung Cancer 49 suppl 1 (2005) S49-S52
6. Rusch V.W., and Venkatraman E. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 68 (1999) 1799-1804
7. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., et al. Resection margins, extrapleural nodal status and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117 (1999) 54-63 discussion 63-5
8. Perrot M.D., Karl U., Anraku M., et al. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 133 (2007) 111-116
9. Pilling J.E., Stewart D.J., Martin-Ucar A.E., Muller S., Byrne K.J., and Waller D.A. The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma. Eur J Cardiothorac Surg 25 (2004) 497-501
10. Rusch V.W., and Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 111 (1996) 815-816
11. Schouwink J.H., Kool L.S., Rutgers E.J., et al. The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma. Ann Thorac Surg 75 (2003) 1715-1719
12. Rice D.C., Erasmus J.J., Stevens C.W., et al. Extended surgical staging for potentially resectable malignant pleural mesothelioma. Ann Thorac Surg 80 (2005) 1988-1993
13. Flores R.M., and Alam N. Treatment of malignant pleural mesothelioma: pleurectomy with adjuvant therapy. Operative Techniques in Thoracic and Cardiovascular Surgery: A Comparative Atlas 11 (2006) 57-75
14. Flores R.M., Akhurst T., Gonen M., Larson S.M., and Rusch V.W. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J Thorac Cardiovas Surg 126 (2003) 11-15
15. Yasufuku K., Nakajima T., Motoori K., et al. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest 130 (2006) 710-718
16. Vincent B.U., EL Bayomi E., Hoffman B., et al. Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration. Ann Thorac Surg 85 (2008) 224-230
17. Stewart D.J., Martin-Ucar A.E., Pilling J.E., Edwards J.G., Byrne K.J., and Waller D.A. The effect of extent of local resection on pattern of disease progression in malignant pleural mesothelioma. Ann Thorac Surg 78 (2004) 245-252
18. Aziz T., Jilaihawi A., and Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg 2 (2002) 298-305
19. Chailleux E., Dobouis G., Pioche D., de Lajartre A.Y., Rembeaux A., and Germaud P. Prognostic factors in diffuse malignant mesothelioma. A study of 167 patients. Chest 93 (1998) 159-162
20. Maggi G., Casadio C., Cianci R., Rena O., and Ruffini E. Trimodality management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 19 (2001) 346-350